Dr. Craig A. McKeown, MD

Dr. McKeown practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. McKeown's NPI, 1215952171, was assigned on July 13, 2006. Dr. McKeown graduated from Feinberg School of Medicine in 1971. Dr. McKeown holds Florida license ME83512.

Dr. McKeown's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. McKeown's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. The medical group on file is University of Miami Health System. Dmand AI also links Dr. McKeown to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKeown practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. McKeown's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. McKeown is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. McKeown's licenses on file in 6 states: Florida, Nevada, Texas, Massachusetts, Maryland and Ohio.

Dmand AI lists eye infection or inflammation and vision problems among the conditions Dr. McKeown treats.

CMS data shows 140 Medicare services from Dr. McKeown across 4 procedure codes in 2024, for 102 Medicare patients. Medicare paid $7,223 for them.

CMS counts 102 Medicare patients who saw Dr. McKeown in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have high cholesterol, and 59% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McKeown's median patient age at 14, with 50% women.

In 2018, Dr. McKeown wrote 11 Medicare Part D claims. They cover 1 drug, with $140 in total drug cost. In 2016, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. McKeown for performance year 2024, reported as part of a group. Dr. McKeown accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 48 papers to Dr. McKeown, published from 2009 to 2024. 2020 was the busiest year, with 7. The most frequent topics are Strabismus, Oculomotor Muscles and Abnormalities, Multiple. Dr. McKeown has published most often in J AAPOS. Dr. McKeown's most frequent co-authors are Kara Marie Cavuoto, MD, Hilda Capo, MD and Stephen G. Schwartz, MD.

CMS Open Payments shows 6 general payments to Dr. McKeown from 5 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Mallinckrodt LLC paid the most, $141.

Dmand AI lists 7 awards for Dr. McKeown, most recently America's Top Doctors in 2014.

Dr. McKeown graduated from Feinberg School of Medicine in 1971. Dr. McKeown is a member of AAO.

Dr. McKeown is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.